Literature DB >> 24028375

Aggrecan- and COMP-loaded poly-(lactic-co-glycolic acid) nanoparticles stimulate chondrogenic differentiation of human mesenchymal stem cells.

Su Yeon Jeon1, Ji Sun Park, Han Na Yang, Dae Gyun Woo, Keun-Hong Park.   

Abstract

During embryogenesis, specific proteins expressed in cells have key roles in the formation of differentiated cells and tissues. Delivery of specific proteins into specific cells, both in vitro and in vivo, has proved to be exceedingly difficult. In this study, we developed a safe and efficient protein delivery system using encapsulation of proteins into biodegradable poly-(lactic-co-glycolic acid) (PLGA) nanoparticles (NPs). The PLGA NPs were used to deliver proteins into human mesenchymal stem cells (hMSCs). Fluorescent markers loaded into the PLGA NPs were used to verify the internalization of NPs into hMSCs using FACS analysis and confocal microscopy. With these methods, we demonstrated that the encapsulated model proteins are readily delivered into hMSCs, released from the NP vehicles, and, finally, moved into the cytosols. Using chondrogenesis-related proteins such as aggrecan and cartilage oligomeric matrix protein (COMP), chondrogenic differentiation of hMSCs treated with aggrecan and COMP encapsulated PLGA NPs was clearly observed and caused to differentiate into chondrocytes.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24028375     DOI: 10.1089/scd.2013.0311

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  2 in total

1.  Hematopoietic and mesenchymal stem cells: polymeric nanoparticle uptake and lineage differentiation.

Authors:  Ivonne Brüstle; Thomas Simmet; Gerd Ulrich Nienhaus; Katharina Landfester; Volker Mailänder
Journal:  Beilstein J Nanotechnol       Date:  2015-02-05       Impact factor: 3.649

Review 2.  ADAMTS-12: a multifaced metalloproteinase in arthritis and inflammation.

Authors:  Jianlu Wei; Brendon Richbourgh; Tanghong Jia; Chuanju Liu
Journal:  Mediators Inflamm       Date:  2014-04-28       Impact factor: 4.711

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.